Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥

Registered PT-141 studies

This page lists ClinicalTrials.gov records that name PT-141 among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.

View PT-141 in the catalog

10Registered studies
0Recruiting
9Completed
4With results posted

10 of 4,477 registered studies · showing 1–10

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

CompletedPhase 3PT-141
NCT ID
NCT04943068
Sponsor
Kwang Dong Pharmaceutical co., ltd.
Registry dates
2021-05-10 – 2023-05-16
Enrollment
193 registered participants
Locations
South Korea
Conditions listed
Hypoactive Sexual Desire Disorder